GHRS
NASDAQ · Pharmaceuticals
Gh Research Plc
$18.61
+0.17 (+0.92%)
Open$18.56
Previous Close$18.44
Day High$18.78
Day Low$18.13
52W High$31.44
52W Low$12.04
Volume—
Avg Volume388.0K
Market Cap1.28B
P/E Ratio—
EPS$-0.99
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+159.2% upside
Current
$18.61
$18.61
Target
$48.23
$48.23
$34.28
$48.23 avg
$66.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 289.57M | 263.52M | 305.92M |
| Net Income | 46.13M | 45.80M | 47.46M |
| Profit Margin | 15.9% | 17.4% | 15.5% |
| EBITDA | 85.32M | 72.54M | 88.44M |
| Free Cash Flow | 28.26M | 23.23M | 28.03M |
| Rev Growth | +11.0% | +19.2% | +2.7% |
| Debt/Equity | 0.68 | 0.55 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |